DIFFUSION PHARMACEUTICALS IN - COM PAR

CUSIP: 253748305

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class
Equity / COM PAR
Total 13F shares
5,119,831
Share change
-152,859
Total reported value
$4,310,000
Price per share
$0.84
Number of holders
22
Value change
-$163,852
Number of buys
13
Number of sells
13

Quarterly Holders Quick Answers

What is CUSIP 253748305?
CUSIP 253748305 identifies 253748305 - DIFFUSION PHARMACEUTICALS IN - COM PAR in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of DIFFUSION PHARMACEUTICALS IN - COM PAR as of Q3 2020

As of 30 Sep 2020, DIFFUSION PHARMACEUTICALS IN - COM PAR was held by 22 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,119,831 shares. The largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, Virtu Financial LLC, NORTHERN TRUST CORP, GOLDMAN SACHS GROUP INC, CITADEL ADVISORS LLC, Raymond James Financial Services Advisors, Inc., and ADVISOR GROUP HOLDINGS, INC.. This page lists 22 institutional shareholders reporting positions in this security for the Q3 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.